Michał Kostrzanowski, MD

Articles by Michał Kostrzanowski, MD

Synchronous Endometrial and Ovarian Cancers: A Case Study and Literature Review

ByMichał Kostrzanowski, MD,Adam Górski, MD,Grzegorz Panek, MD, PhD,Grzegorz Ziółkowski, MD,Agata Mandes, MD,Filip Dąbrowski, MD, PhD

April 23rd 2026

Extreme Case of Surgical Port Metastasis in Ovarian Cancer

ByMichał Kostrzanowski, MD,Grzegorz Ziółkowski, MD,Filip Dąbrowski, MD, PhD

March 5th 2024

We present the case of a 51-year-old woman with metastatic International FIGO stage IIIC ovarian cancer who had delayed her therapy after initial laparoscopy due to COVID-19 infection and presented with an extreme case of surgical port metastasis.

Latest Updated Articles

Extreme Case of Surgical Port Metastasis in Ovarian Cancer
March 5th 2024
Synchronous Endometrial and Ovarian Cancers: A Case Study and Literature Review
April 23rd 2026

Trending on CancerNetwork

124 Real-World Progression-Free Survival 2 and Tumor Response of CDK4/6is + Aromatase Inhibitor in Patients With HR+/HER2– Metastatic Breast Cancer

122 Adjuvant Ribociclib (RIB) Plus Nonsteroidal Aromatase Inhibitor (NSAI) in Patients With HR+/HER2− Early Breast Cancer (EBC): NATALEE 5-Year Outcomes

FDA Approves Zenocutuzumab in NRG1+ Cholangiocarcinoma Post Systemic Therapy

TIP126 TroFuse-011: A Phase 3, Randomized, Open-Label Study of Sacituzumab Tirumotecan With or Without Pembrolizumab vs Treatment of Physician’s Choice for Previously Untreated Locally Recurrent Unresectable or Metastatic Triple-Negative Breast Cancer With PD-L1 Combined Positive Score <10